Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials Review Article (Web of Science)

Open Access International Collaboration

cited authors

  • Mousavi, Asma; Shojaei, Shayan; Soleimani, Hamidreza; Semirani-Nezhad, Davood; Ebrahimi, Pouya; Zafari, Ali; Ebrahimi, Rasoul; Roozbehi, Khatere; Harrison, Anil; Syed, Mushabbar A.; Kuno, Toshiki; Askari, Mani Khorsand; Almandoz, Jaime P.; Jun, John; Hosseini, Kaveh

publication date

  • February 24, 2025

webpage

published in

category

keywords

  • Adverse events
  • GLP-1RA
  • Hospitalization for heart failure
  • Major adverse cardiovascular events
  • Metabolic outcomes
  • SGTL-2i

volume

  • 17

issue

  • 1